Daily Archives: 15/10/2011

Breach of agreement-Onyx Vs Bayer-Sorafenib derivative

This is about breach of contract/collaborative agreement between onyx and bayer. [Press release] Recently Onyx and Bayer announced settlement agreement regarding the drug called “Regorafenib”(BAY73-4506). Regorafenib is structurally similar to sorafenib except a Fluoro substitution on sorafenib moiety. Sorafenib Regorafenib … Continue reading

Posted in Drug developments & targets | Tagged , , , | Leave a comment